Literature DB >> 19799014

[The role of serum leptin in infants with wheezing after respiratory syncytial virus infected].

Zhuang-Gui Chen1, Ming Li, Jing-Zhi Ji, Yong Zhang, Hong Chen, Yan-Feng Chen, Fen-Hua Chen, Li Deng.   

Abstract

OBJECTIVE: To determine the role of serum leptin in infants with wheezing after respiratory syncytial virus infected.
METHODS: 43 infants infected with RSV were given blood samples to detect leptin concentration with radioimmunoassays (RIA) within 24 hours after admission into hospital, discharged and 12 weeks later. Then, they were followed up for 2 years. 10 healthy children of the same age served as controls.
RESULTS: 41.9% infants developed asthma after infected with RSV. Compared to control group, the serum level of leptin in the asthma group and non-asthma group were significantly higher before treatment (t = 3.41 and 2.64 respectively, P < 0.05). When they were discharged, the serum level of leptin in the asthma group was significantly higher than that in non-asthma group and control group (t = 5.74 and 6.23, respectively, P < 0.05). 12 weeks later, the serum level of leptin in the asthma group was still significantly higher than that in non-asthma group and control group (t = 6.32 and 6.11, respectively, P < 0.05), but there were no difference between non-asthma group and control group (t = 0.81, P > 0.05).
CONCLUSION: The serum level of leptin in infants with asthma after RSV infected was higher than that in healthy and non-asthma children. Persistent higher level of leptin may play an important role in infants with asthma after RSV infected.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19799014

Source DB:  PubMed          Journal:  Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi        ISSN: 1003-9279


  1 in total

1.  Increased Adiposity Associated With Increased Length of Stay for Infants With Bronchiolitis.

Authors:  Meredith B Haag; Jesse Goldfarb; Jared P Austin; Michelle Noelck; Byron A Foster
Journal:  Hosp Pediatr       Date:  2020-06-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.